©2004 Millennium Pharmaceuticals, Inc. © 2004 Millennium Pharmaceuticals Inc. Opportunities and Challenges in Utilizing Biomarkers for Drug Development.
T15 ancova
JesseColeASSIPPoster_Version2_080814
Understanding and Addressing Provider Contribution to Disparities Michelle van Ryn, Ph.D., M.P.H. Director, Colorectal Cancer Quality Enhancement Research.
Propensity Score Matching Lava Timsina Kristina Rabarison CPH 786-001 Doctoral Seminar Fall 2012.
MRD in myeloma UKMF Spring Day Assessment of disease response, CR and beyond. Roger Owen St James’s Institute of Oncology Leeds, UK.
EXPERIMENTAL DESIGN Random assignment Who gets assigned to what? How does it work What are limits to its efficacy?
Racial disparities in pain: A social-cognitive perspective Diana Burgess, PhD Core Investigator Center for Chronic Disease Outcomes Research (CCDOR) Assistant.
Paths to precision medicine: Subgroup Identification in Clinical Trials Xin Huang, Yan Sun, V. Devanarayan Exploratory Statistics AbbVie Inc. April. 15,
